Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia

NCT01599286 is registered in ClinicalTrials.gov with Mendel Tuchman as lead sponsor.

NCT NCT01599286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia
Lead sponsor
Mendel Tuchman
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2012
Completion date
April 30, 2020
Enrollment
35 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

carbamoyl-phosphate synthase i deficiency disease, methylmalonic acidemia, ornithine carbamoyltransferase deficiency, propionic acidemia, type i and/or type ii